HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
IQCB1
IQ motif containing B1
Chromosome 3 Β· 3q13.33|3q21.1
NCBI Gene: 9657Ensembl: ENSG00000173226.18HGNC: HGNC:28949UniProt: Q15051
77PubMed Papers
22Diseases
0Drugs
94Pathogenic Variants
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
protein bindingcalmodulin bindingenzyme bindingprotein-macromolecule adaptor activitySenior-Loken syndrome 5Senior-Loken syndromeLeber congenital amaurosisnephronophthisis
✦AI Summary

IQCB1 (IQ motif containing B1) is a ciliary protein essential for ciliogenesis and photoreceptor function. It associates with CEP290/NPHP6 to regulate early cilia formation 12 and controls BBSome complex integrity, particularly the presence of BBS2 and BBS5 subunits, facilitating ciliary targeting of BBSome cargos 3. IQCB1 dysfunction impairs ciliary axoneme structure and outer segment development, with reduced CEP290 protein levels providing a mechanism for aberrant ciliary gating 4. IQCB1 mutations cause Leber congenital amaurosis (LCA) and Senior-Loken syndrome (SLS), characterized by early-onset severe cone-rod dystrophy with rapid photoreceptor degeneration 56. Patients with IQCB1 variants present retinopathy as early as infancy, with nystagmus as the most common initial sign in 86.4% of cases and extinguished electroretinograms in most patients 7. While cone photoreceptors are preferentially preserved, most patients develop severe vision loss with dysfunctional retinal structure 56. Nephronophthisis develops later, with renal failure appearing around age 26 years in approximately half of patients 6. IQCB1-retinopathy shows phenotypic variability; notably, dissociation between severely reduced retinal function and relatively preserved retinal structure makes it a promising candidate for gene therapy intervention via AAV-mediated gene augmentation 46.

Sources cited
1
IQCB1 association with CEP290/NPHP6 in early cilia formation
PMID: 21565611
2
IQCB1 association with CEP290/NPHP6 in early cilia formation
PMID: 23446637
3
IQCB1 regulates BBSome complex integrity and ciliary targeting of BBSome cargos
PMID: 25552655
4
IQCB1 mutations cause aberrant ciliary axonemes and impaired outer segment development; reduced CEP290 protein in patient cells; AAV-mediated gene augmentation rescues disease phenotype in retinal organoids
PMID: 36084637
5
IQCB1-LCA involves early-onset rapid rod degeneration with preserved cone nuclei; appropriate candidate for cone-directed gene augmentation therapy
PMID: 21245082
6
IQCB1-retinopathy is severe early-onset cone-rod dystrophy with stable OCT findings; renal failure develops around age 26.3 years in some patients; dissociation between retinal function loss and structure preservation supports gene therapy candidacy
PMID: 38522724
7
IQCB1 variants cause earlier-onset retinopathy in Senior-Loken syndrome; nystagmus in 86.4% of IQCB1 patients; extinguished cone and rod responses in 96.4% of patients
PMID: 36990420
Disease Associationsβ“˜22
Senior-Loken syndrome 5Open Targets
0.71Strong
Senior-Loken syndromeOpen Targets
0.69Moderate
Leber congenital amaurosisOpen Targets
0.68Moderate
nephronophthisisOpen Targets
0.56Moderate
Retinal dystrophyOpen Targets
0.55Moderate
retinopathyOpen Targets
0.43Moderate
genetic disorderOpen Targets
0.41Moderate
ciliopathyOpen Targets
0.37Weak
eye diseaseOpen Targets
0.37Weak
retinitis pigmentosaOpen Targets
0.33Weak
multiple sclerosisOpen Targets
0.31Weak
obesityOpen Targets
0.28Weak
Bardet-Biedl syndromeOpen Targets
0.27Weak
coronary atherosclerosisOpen Targets
0.22Weak
systemic lupus erythematosusOpen Targets
0.22Weak
Leber congenital amaurosis 10Open Targets
0.18Weak
atrial fibrillationOpen Targets
0.06Suggestive
asthmaOpen Targets
0.06Suggestive
liver cancerOpen Targets
0.04Suggestive
neoplasmOpen Targets
0.04Suggestive
Leber congenital amaurosis 10UniProt
Senior-Loken syndrome 5UniProt
Pathogenic Variants94
NM_001023570.4(IQCB1):c.424_425del (p.Phe142fs)Pathogenic
Senior-Loken syndrome 5|Leber congenital amaurosis|Nephronophthisis|not provided|Retinal dystrophy
β˜…β˜…β˜†β˜†2025β†’ Residue 142
NM_001023570.4(IQCB1):c.1036G>T (p.Glu346Ter)Pathogenic
Senior-Loken syndrome 5|Nephronophthisis|Leber congenital amaurosis
β˜…β˜…β˜†β˜†2025β†’ Residue 346
NM_001023570.4(IQCB1):c.1465C>T (p.Arg489Ter)Pathogenic
Senior-Loken syndrome 5|Nephronophthisis|Retinal dystrophy|not provided|Leber congenital amaurosis
β˜…β˜…β˜†β˜†2025β†’ Residue 489
NM_001023570.4(IQCB1):c.825_828del (p.Arg275fs)Pathogenic
Senior-Loken syndrome 5|Nephronophthisis|IQCB1-related disorder|Retinal disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 275
NM_001023570.4(IQCB1):c.1518_1519del (p.His506fs)Pathogenic
Senior-Loken syndrome 5|Retinitis pigmentosa|not provided|Nephronophthisis|IQCB1-related disorder|Retinal dystrophy
β˜…β˜…β˜†β˜†2025β†’ Residue 506
NM_001023570.4(IQCB1):c.1090C>T (p.Arg364Ter)Pathogenic
not provided|Nephronophthisis|Senior-Loken syndrome 5
β˜…β˜…β˜†β˜†2025β†’ Residue 364
NM_001023570.4(IQCB1):c.214C>T (p.Arg72Ter)Pathogenic
not provided|Leber congenital amaurosis|Nephronophthisis|Senior-Loken syndrome 5
β˜…β˜…β˜†β˜†2025β†’ Residue 72
NM_001023570.4(IQCB1):c.1381C>T (p.Arg461Ter)Pathogenic
Senior-Loken syndrome 5|Nephronophthisis|Retinal dystrophy|not provided|Renal dysplasia and retinal aplasia|Inborn genetic diseases|IQCB1-related disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 461
NM_001023570.4(IQCB1):c.897_900dup (p.Ile301fs)Pathogenic
Nephronophthisis|not provided|Senior-Loken syndrome 5|Retinal dystrophy
β˜…β˜…β˜†β˜†2025β†’ Residue 301
NM_001023570.4(IQCB1):c.100G>T (p.Glu34Ter)Pathogenic
Nephronophthisis|Senior-Loken syndrome 5
β˜…β˜…β˜†β˜†2024β†’ Residue 34
NM_001023570.4(IQCB1):c.757del (p.Cys253fs)Pathogenic
Nephronophthisis|IQCB1-related disorder|Senior-Loken syndrome 5
β˜…β˜…β˜†β˜†2024β†’ Residue 253
NM_001023570.4(IQCB1):c.1333C>T (p.Arg445Ter)Pathogenic
Nephronophthisis|Senior-Loken syndrome 5|Leber congenital amaurosis
β˜…β˜…β˜†β˜†2024β†’ Residue 445
NM_001023570.4(IQCB1):c.1504C>T (p.Arg502Ter)Pathogenic
Nephronophthisis|Retinal dystrophy|Senior-Loken syndrome 5
β˜…β˜…β˜†β˜†2024β†’ Residue 502
NM_001023570.4(IQCB1):c.1522_1523dup (p.Ala509fs)Pathogenic
Senior-Loken syndrome 5|Nephronophthisis
β˜…β˜…β˜†β˜†2024β†’ Residue 509
NM_001023570.4(IQCB1):c.817G>T (p.Glu273Ter)Pathogenic
not provided|Senior-Loken syndrome 5|Nephronophthisis
β˜…β˜…β˜†β˜†2024β†’ Residue 273
NM_001023570.4(IQCB1):c.577C>T (p.Gln193Ter)Likely pathogenic
Senior-Loken syndrome 5
β˜…β˜…β˜†β˜†2024β†’ Residue 193
NM_001023570.4(IQCB1):c.488-1G>APathogenic
Senior-Loken syndrome 5|Nephronophthisis
β˜…β˜…β˜†β˜†2024
NM_001023570.4(IQCB1):c.1363C>T (p.Arg455Ter)Pathogenic
Renal dysplasia and retinal aplasia|Nephronophthisis|Senior-Loken syndrome 5|Retinal dystrophy
β˜…β˜…β˜†β˜†2024β†’ Residue 455
NM_001023570.4(IQCB1):c.264-2A>TPathogenic
not provided|Nephronophthisis|Senior-Loken syndrome 5
β˜…β˜…β˜†β˜†2024
NM_001023570.4(IQCB1):c.994C>T (p.Arg332Ter)Pathogenic
Retinal dystrophy|Nephronophthisis|Senior-Loken syndrome 5
β˜…β˜…β˜†β˜†2024β†’ Residue 332
View on ClinVar β†—
Related Genes
RAB8AProtein interaction96%CALM3Protein interaction83%AHI1Protein interaction82%NPHP1Protein interaction81%OFD1Protein interaction81%ATXN10Protein interaction81%
Tissue Expression6 tissues
Bone Marrow
100%
Ovary
63%
Brain
46%
Lung
45%
Heart
31%
Liver
31%
Gene Interaction Network
Click a node to explore
IQCB1RAB8ACALM3AHI1NPHP1OFD1ATXN10
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt Q15051
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
0.89LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.67 [0.51–0.89]
RankingsWhere IQCB1 stands among ~20K protein-coding genes
  • #6,170of 20,598
    Most Researched77
  • #820of 5,498
    Most Pathogenic Variants94 Β· top quartile
  • #7,957of 17,882
    Most Constrained (LOEUF)0.89
Genes detectedIQCB1
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
PMID: 27336129
1.00
2
Pathogenic Variants in CEP290 or IQCB1 Cause Earlier-Onset Retinopathy in Senior-Loken Syndrome Compared to Those in INVS, NPHP3, or NPHP4.
PMID: 36990420
Am J Ophthalmol Β· 2023
0.90
3
IQCB1 (NPHP5)-Retinopathy: Clinical and Genetic Characterization and Natural History.
PMID: 38522724
Am J Ophthalmol Β· 2024
0.80
4
Genetic and Clinical Profile of Retinopathies Due to Disease-Causing Variants in Leber Congenital Amaurosis (LCA)-Associated Genes in a Large German Cohort.
PMID: 37240262
Int J Mol Sci Β· 2023
0.70
5
InΒ vitro modeling and rescue of ciliopathy associated with IQCB1/NPHP5 mutations using patient-derived cells.
PMID: 36084637
Stem Cell Reports Β· 2022
0.60